Scancell Holdings plc (SCLP.L) said that it appointed Phil L'Huillier as Chief Executive Officer. He will join the company and become a member of the Company's Board of Directors, effective 18 November 2024. Current Chief Executive Officer, Professor Lindy Durrant, will remain in the CEO role until that date. She will also retain her position as Chief Scientific Officer, working closely alongside Dr L'Huillier, and will remain on the Company's Board of Directors.
Prior to joining Scancell, Dr L'Huillier served as CEO and Managing Director of CatalYm GmbH. Prior to this, he was Head of the European Innovation Hub & Business Development for Europe, the Middle East and Africa at global pharmaceutical company Merck Sharp & Dohme.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.